Indication

Walking impairment due to multiple sclerosis

Walking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system. Read more about Walking impairment due to multiple sclerosis

12 drugs 11 manufacturers

Advertisement

Drugs that treat it

Common Walking impairment due to multiple sclerosis therapies.

Showing 1–9 of 12 drugs

DALFAMPRIDINE

AMINOPYRIDINES FOR NEUROLOGICAL DISORDERS·WALKING IMPAIRMENT DUE TO MULTIPLE SCLEROSIS
SUN PHARMACEUTI
Filter & compare in the drug finder →Opens the drug finder with Walking impairment due to multiple sclerosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Walking impairment due to multiple sclerosis.

Walking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system.

It arises from immune-mediated inflammatory demyelination and axonal transection across motor, sensory, and cerebellar pathways, disrupting signal conduction between the brain, spinal cord, and peripheral musculature.

Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue.

As a progressive functional complication, it severely compromises independent ambulation and serves as a key benchmark of advancing physical disability in this patient population.

Personalize your experience

Follow Walking impairment due to multiple sclerosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it